About ST PHARM
ST PHARM is a company based in Siheung-si (South Korea) founded in 2008. The company has 664 employees. ST PHARM offers products and services including CDMO Services, CRO Services, Oligonucleotide Services, and mRNA Services.
- Headquarter Siheung-si, South Korea
- Employees 664
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website stpharm.co.kr
- Social LinkedIn X Facebook
- Legal Name St Pharm Co., Ltd.
- Annual Revenue$229.66 M (USD)21.16as on Dec 31, 2025
- Net Profit$38.08 M (USD)58.42as on Dec 31, 2025
- EBITDA$58.44 M (USD)59.16as on Dec 31, 2025
- Investors
- Employee Count664
Products & Services of ST PHARM
ST PHARM offers a comprehensive portfolio of products and services, including CDMO Services, CRO Services, Oligonucleotide Services, and mRNA Services.
Contract development and manufacturing for pharmaceuticals and gene therapy.
Contract research and development for biotechnology and R&D projects.
Manufacturing and development of oligonucleotide-based therapies.
Contract production and research for mRNA technologies.
Funding Insights of ST PHARM
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of ST PHARM with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2015 | – | Private Equity Round | – | – |
1 investors in total: 1 institutional.
Investors in ST PHARM
ST PHARM has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include E&Investment.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | eninvestment.co.kr | - |
Investor details for ST PHARM
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ST PHARM
2 people are tracked at ST PHARM (2 in leadership); the tracked headcount is 664.
| Name | Role | Group |
|---|---|---|
Mooje Sung | CEO | Leadership |
Jun Young Choi | Head Of Research And Development | Leadership |
Complete people profiles for ST PHARM
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of ST PHARM
ST PHARM is a publicly listed company on the KRX with ticker symbol 237690 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date23 Jun 2016
- Listed onKRX: 237690
- Listed entityST PHARM CO., LTD.
- Exchange sectorHealth technology
- ISINKR7237690003
- Share price89,000.00 KRW (-4.2% on the day) · 2026-10-12
- Market capitalisation1,939,439,708,519.00 KRW
- Price to earnings24.1
- EPS (diluted, trailing year)3,699.86 KRW
- Dividend yield0.54%
- Volume (last session)73,964
Financials of ST PHARM
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 331.68B KRW | 54.99B KRW | 84.40B KRW |
| 2024 | 273.75B KRW | 34.71B KRW | 53.03B KRW |
| 2023 | 284.99B KRW | 19.58B KRW | 54.06B KRW |
| 2022 | 249.32B KRW | 18.00B KRW | 35.45B KRW |
| 2021 | 165.64B KRW | 3.31B KRW | 19.99B KRW |
Detailed financial statements for ST PHARM
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of ST PHARM
3 dated milestones of ST PHARM across 8 years, from founding to its latest funding, stage changes and deals.
- Founded ST PHARM is founded.
- Funding First funding round.
- IPO Lists on the stock exchange (IPO).
Web traffic of ST PHARM
The website of ST PHARM (stpharm.co.kr) receives about 15.8K visits a month and ranks #1,807,075 among all websites worldwide, #2,458 in Biotechnology and Pharmaceuticals.
- Monthly visits15.8K
▲ 18.4% vs previous month
- Unique visitors6K
per month
- Global rank#1,807,075
among all websites
- Category rank#2,458
Health · Biotechnology and Pharmaceuticals
- Bounce rate56%
- Pages per visit1.8
- Average visit31 sec
- DevicesDesktop 26% · Mobile 74%
Websites whose visitors overlap most with ST PHARM. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| cordenpharma.com | 100% | 26.2K | #789,402 | View details | |
pqmgmp.co.kr | pqmgmp.co.kr | 74% | – | #4,257,834 | – |
medipana.com | medipana.com | 54% | – | #266,587 | – |
rapportian.com | rapportian.com | 53% | – | #392,999 | – |
yakup.com | yakup.com | 53% | – | #118,603 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for ST PHARM
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on St Pharm
Complete news archive for ST PHARM
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to ST PHARM
10 companies that operate in the same segment as ST PHARM (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ST PHARM
ST PHARM was founded in 2008 and raised its 1st funding round 7 years after it was founded.
ST PHARM is headquartered in Siheung-si, South Korea. It is registered at Siheung-si, Gyeonggi-do, South Korea.
ST PHARM has 664 employees.
Annual revenue of ST PHARM is $229.66M as on Dec 31, 2025.
Founded in 2008, ST PHARM functions as a contract development and manufacturing organization in the pharmaceutical sector. Services are extended across oligonucleotide, mRNA, and small molecule modalities, including research and development with virtual and global capabilities. Analytical testing and quality control are conducted to support clients from early-stage drug research to commercial production stages. Operations are based in South Korea.
ST PHARM offers CDMO Services, CRO Services, Oligonucleotide Services, and mRNA Services.
Yes, ST PHARM is publicly traded on KRX under the ticker symbol 237690.
ST PHARM has 1 investor. Key investors include E&Investment.